Tanaka Toshihiro, Sakaguchi Hiroshi, Anai Hiroshi, Yamamoto Kiyosei, Morimoto Kengo, Nishiofuku Hideyuki, Kichikawa Kimihiko
Department of Radiology, Nara Medical University, 840 Shijo-cho Kashihara, 634 to 8522, Japan.
J Vasc Interv Radiol. 2004 Oct;15(10):1089-97. doi: 10.1097/01.RVI.0000131220.07444.7B.
To identify the drug infusion vessel for use in obtaining the best drug distribution in arterial infusion chemotherapy for advanced pancreatic cancer.
In 16 cases of advanced pancreatic cancer (pancreatic head, n = 12; pancreatic body and/or tail, n = 4), computed tomography during arterial injection of contrast material was performed at the time of angiography. The sites of catheter placement were celiac artery, superior mesenteric artery, and their branches, such as gastroduodenal artery, inferior pancreatico-duodenal artery, or dorsal pancreatic artery.
In the cases of pancreatic head cancer, all except one with hepatomesenteric vascular variation were supplied by the celiac artery and superior mesenteric artery (dual supply). In the cases of pancreatic body and/or tail cancer, two were supplied by celiac artery alone and two showed dual supply. In the cases of pancreatic head cancer, when the areas supplied by the main trunk were compared with those supplied by its branches, three of nine cases on the celiac artery side and four cases on the superior mesenteric artery side showed that the areas were not consistent, with a partial defect observed in the areas supplied by branches of the superior mesenteric artery. In the cases of pancreatic body and/or tail cancer, on both sides, one of two cases was not consistent.
To achieve optimal drug distribution in arterial infusion chemotherapy for advanced pancreatic cancer, drug infusion via both the celiac artery and superior mesenteric artery is required in the majority of cases. In many cases, optimal drug distribution is not attainable with drug infusion via a branch; therefore, drug infusion should be administered via the main trunk.
确定在晚期胰腺癌动脉灌注化疗中用于实现最佳药物分布的药物输注血管。
对16例晚期胰腺癌患者(胰头癌12例;胰体和/或胰尾癌4例)在血管造影时进行动脉注射造影剂后的计算机断层扫描。导管放置部位为腹腔动脉、肠系膜上动脉及其分支,如胃十二指肠动脉、胰十二指肠下动脉或胰背动脉。
在胰头癌病例中,除1例存在肝肠系膜血管变异外,其余均由腹腔动脉和肠系膜上动脉供血(双重供血)。在胰体和/或胰尾癌病例中,2例仅由腹腔动脉供血,2例为双重供血。在胰头癌病例中,将主干供血区域与其分支供血区域进行比较时,腹腔动脉侧9例中有3例、肠系膜上动脉侧4例显示供血区域不一致,肠系膜上动脉分支供血区域存在部分缺损。在胰体和/或胰尾癌病例中,两侧各有1例(共2例)不一致。
为在晚期胰腺癌动脉灌注化疗中实现最佳药物分布,大多数情况下需要通过腹腔动脉和肠系膜上动脉进行药物输注。在许多情况下,通过分支进行药物输注无法实现最佳药物分布;因此,应通过主干进行药物输注。